Although the tilsotolimod plus ipilimumab treatment did not meet its co-primary endpoint, these results are a valuable addition to the literature with respect to second-line treatment options in this ...

(HealthDay News) — Seventeen percent of American adults surveyed said they want to see Medicaid funding decreased, while 42% said funding should increase, and 40% said it should be kept about the same ...